Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of México
Descripción del Articulo
Introduction. The joint prescription of several medications favors the occurrence of drug interactions, reducing the expected effect of the drug, and also favors the appearance of unexpected side effects. Objective. Document the prevalence of drug interactions in patients hospitalized in an internal...
Autores: | , , |
---|---|
Formato: | artículo |
Fecha de Publicación: | 2021 |
Institución: | Universidad Nacional Mayor de San Marcos |
Repositorio: | Revistas - Universidad Nacional Mayor de San Marcos |
Lenguaje: | español |
OAI Identifier: | oai:ojs.csi.unmsm:article/21176 |
Enlace del recurso: | https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/21176 |
Nivel de acceso: | acceso abierto |
Materia: | Interacciones farmacológicas polifarmacia farmacovigilancia hospitalización Medicina Interna drug interactions polypharmacy pharmacovigilance hospitalization internal medicine |
id |
REVUNMSM_33f0454b2b46ed5ab4ea8e4fbe1bc20b |
---|---|
oai_identifier_str |
oai:ojs.csi.unmsm:article/21176 |
network_acronym_str |
REVUNMSM |
network_name_str |
Revistas - Universidad Nacional Mayor de San Marcos |
repository_id_str |
|
dc.title.none.fl_str_mv |
Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of México Prevalencia de interacciones farmacológicas en pacientes hospitalizados en el servicio de medicina interna de un hospital general de México |
title |
Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of México |
spellingShingle |
Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of México Palacios-Rosas, Erika Interacciones farmacológicas polifarmacia farmacovigilancia hospitalización Medicina Interna drug interactions polypharmacy pharmacovigilance hospitalization internal medicine |
title_short |
Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of México |
title_full |
Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of México |
title_fullStr |
Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of México |
title_full_unstemmed |
Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of México |
title_sort |
Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of México |
dc.creator.none.fl_str_mv |
Palacios-Rosas, Erika León-Domínguez, Marla P. Castro-Pastrana, Lucila I. Palacios-Rosas, Erika León-Domínguez, Marla P. Castro-Pastrana, Lucila I. |
author |
Palacios-Rosas, Erika |
author_facet |
Palacios-Rosas, Erika León-Domínguez, Marla P. Castro-Pastrana, Lucila I. |
author_role |
author |
author2 |
León-Domínguez, Marla P. Castro-Pastrana, Lucila I. |
author2_role |
author author |
dc.subject.none.fl_str_mv |
Interacciones farmacológicas polifarmacia farmacovigilancia hospitalización Medicina Interna drug interactions polypharmacy pharmacovigilance hospitalization internal medicine |
topic |
Interacciones farmacológicas polifarmacia farmacovigilancia hospitalización Medicina Interna drug interactions polypharmacy pharmacovigilance hospitalization internal medicine |
description |
Introduction. The joint prescription of several medications favors the occurrence of drug interactions, reducing the expected effect of the drug, and also favors the appearance of unexpected side effects. Objective. Document the prevalence of drug interactions in patients hospitalized in an internal medicine department. Methods. Observational, cross-sectional, retrospective study. It analyzed the drug prescriptions using the drugs.com® “Interactions Checker” tool to detect possible drug interactions found in the clinical records of 118 patients hospitalized in an internal medicine department of a public hospital in Mexico. Results. 78% of patients presented at least one drug interaction; 459 interactions were identified in total with a mean of 4 interactions per patient. 75% were classified as moderate, 13.5% mild, and 11.5% severe. Omeprazole had the highest number of interactions, and the most frequent interaction was furosemide + omeprazole. There was a significant relationship between drug interactions and the number of drugs prescribed (p <0.001). Conclusions. There is a high prevalence of possible drug interactions in the study sample, which should be considered when performing a rational prescription process, thereby ensuring the risk-benefit ratio to obtain a far-reaching positive impact on the patients’ health. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-12-11 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/21176 10.15381/anales.v82i3.21176 |
url |
https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/21176 |
identifier_str_mv |
10.15381/anales.v82i3.21176 |
dc.language.none.fl_str_mv |
spa |
language |
spa |
dc.relation.none.fl_str_mv |
https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/21176/17394 |
dc.rights.none.fl_str_mv |
Derechos de autor 2021 Anales de la Facultad de Medicina http://creativecommons.org/licenses/by-nc-sa/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Derechos de autor 2021 Anales de la Facultad de Medicina http://creativecommons.org/licenses/by-nc-sa/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana |
publisher.none.fl_str_mv |
Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana |
dc.source.none.fl_str_mv |
Anales de la Facultad de Medicina; Vol. 82 No. 3 (2021) Anales de la Facultad de Medicina; Vol. 82 Núm. 3 (2021) 1609-9419 1025-5583 reponame:Revistas - Universidad Nacional Mayor de San Marcos instname:Universidad Nacional Mayor de San Marcos instacron:UNMSM |
instname_str |
Universidad Nacional Mayor de San Marcos |
instacron_str |
UNMSM |
institution |
UNMSM |
reponame_str |
Revistas - Universidad Nacional Mayor de San Marcos |
collection |
Revistas - Universidad Nacional Mayor de San Marcos |
repository.name.fl_str_mv |
|
repository.mail.fl_str_mv |
|
_version_ |
1795238259221069824 |
spelling |
Prevalence of drug interactions in hospitalized patients of the internal medicine service of a general hospital of MéxicoPrevalencia de interacciones farmacológicas en pacientes hospitalizados en el servicio de medicina interna de un hospital general de MéxicoPalacios-Rosas, ErikaLeón-Domínguez, Marla P.Castro-Pastrana, Lucila I.Palacios-Rosas, ErikaLeón-Domínguez, Marla P.Castro-Pastrana, Lucila I.Interacciones farmacológicaspolifarmaciafarmacovigilanciahospitalizaciónMedicina Internadrug interactionspolypharmacypharmacovigilancehospitalizationinternal medicineIntroduction. The joint prescription of several medications favors the occurrence of drug interactions, reducing the expected effect of the drug, and also favors the appearance of unexpected side effects. Objective. Document the prevalence of drug interactions in patients hospitalized in an internal medicine department. Methods. Observational, cross-sectional, retrospective study. It analyzed the drug prescriptions using the drugs.com® “Interactions Checker” tool to detect possible drug interactions found in the clinical records of 118 patients hospitalized in an internal medicine department of a public hospital in Mexico. Results. 78% of patients presented at least one drug interaction; 459 interactions were identified in total with a mean of 4 interactions per patient. 75% were classified as moderate, 13.5% mild, and 11.5% severe. Omeprazole had the highest number of interactions, and the most frequent interaction was furosemide + omeprazole. There was a significant relationship between drug interactions and the number of drugs prescribed (p <0.001). Conclusions. There is a high prevalence of possible drug interactions in the study sample, which should be considered when performing a rational prescription process, thereby ensuring the risk-benefit ratio to obtain a far-reaching positive impact on the patients’ health.Introducción. Los medicamentos han logrado prolongar y mejorar la calidad de vida de los pacientes, pero no garantizan estar libres de riesgo. La prescripción conjunta de varios medicamentos favorece que existan interacciones farmacológicas, disminuyendo el efecto esperado del medicamento y favoreciendo la aparición de efectos secundarios inesperados que ponen en peligro la vida del paciente. Objetivo. Determinar la prevalencia de interacciones farmacológicas en pacientes hospitalizados en un servicio de medicina interna de un hospital general. Métodos. Estudio observacional, transversal y retrospectivo. Se analizaron las prescripciones farmacológicas, utilizando la herramienta “Interactions Checker” de drugs. com® para la detección de posibles interacciones farmacológicas encontradas en los expedientes clínicos de 118 pacientes hospitalizados en un servicio de medicina interna de un hospital público de México. Resultados. El 78% de los pacientes presentaron al menos una interacción farmacológica, se identificaron 459 interacciones en total con una media de 4 interacciones por paciente. El 75% fueron de clasificación moderada, 13,5% leves y 11,5% graves. El omeprazol presentó el mayor número de interacciones y la interacción con mayor frecuencia fue furosemide + omeprazol. Se encontró una relación significativa entre las interacciones farmacológicas y el número de fármacos prescritos (p <0,001). Conclusiones. Existe una alta prevalencia de posibles interacciones farmacológicas en nuestra muestra de estudio, éstas deben ser consideradas para realizar un proceso de prescripción racional, asegurando la relación riesgo-beneficio para obtener un impacto positivo de gran alcance en la salud de los pacientes.Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana2021-12-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/2117610.15381/anales.v82i3.21176Anales de la Facultad de Medicina; Vol. 82 No. 3 (2021)Anales de la Facultad de Medicina; Vol. 82 Núm. 3 (2021)1609-94191025-5583reponame:Revistas - Universidad Nacional Mayor de San Marcosinstname:Universidad Nacional Mayor de San Marcosinstacron:UNMSMspahttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/21176/17394Derechos de autor 2021 Anales de la Facultad de Medicinahttp://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessoai:ojs.csi.unmsm:article/211762021-12-27T16:30:55Z |
score |
13.7211075 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).